BlackRock Fund Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$341M Buy
2,376,204
+102,788
+5% +$14.7M 0.06% 332
2016
Q3
$268M Buy
2,273,416
+55,447
+2% +$6.55M 0.06% 400
2016
Q2
$235M Buy
2,217,969
+59,026
+3% +$6.25M 0.05% 418
2016
Q1
$241M Buy
2,158,943
+35,288
+2% +$3.93M 0.06% 392
2015
Q4
$333M Sell
2,123,655
-48,341
-2% -$7.57M 0.08% 259
2015
Q3
$285M Buy
2,171,996
+48,864
+2% +$6.41M 0.07% 274
2015
Q2
$369M Buy
2,123,132
+105,561
+5% +$18.4M 0.09% 214
2015
Q1
$348M Buy
2,017,571
+45,778
+2% +$7.89M 0.08% 236
2014
Q4
$255M Sell
1,971,793
-33,280
-2% -$4.31M 0.06% 334
2014
Q3
$258M Buy
2,005,073
+82,884
+4% +$10.7M 0.07% 285
2014
Q2
$170M Sell
1,922,189
-61,334
-3% -$5.43M 0.05% 489
2014
Q1
$187M Sell
1,983,523
-5,995
-0.3% -$564K 0.06% 411
2013
Q4
$225M Buy
1,989,518
+141,028
+8% +$15.9M 0.07% 317
2013
Q3
$146M Buy
1,848,490
+145,102
+9% +$11.4M 0.05% 483
2013
Q2
$112M Buy
+1,703,388
New +$112M 0.04% 585